Sherene Loi Selected Research

Sherene Loi Research Topics

Disease

160	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2005
115	Neoplasms (Cancer) 04/2024 - 11/2004
40	Triple Negative Breast Neoplasms 03/2024 - 01/2013
16	Neoplasm Metastasis (Metastasis) 11/2021 - 03/2007
10	Neutropenia 12/2022 - 07/2015
9	Pathologic Complete Response 03/2022 - 06/2012
8	Disease Progression 01/2023 - 07/2015
4	Brain Neoplasms (Brain Tumor) 01/2023 - 11/2017
4	Fatigue 12/2022 - 07/2015
4	Infections 01/2021 - 01/2017
3	Diarrhea 01/2024 - 01/2020
3	Febrile Neutropenia 01/2021 - 07/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 11/2017
2	Adenocarcinoma 01/2024 - 07/2011
2	Dyspnea (Shortness of Breath) 01/2024 - 04/2022
2	Pneumonia (Pneumonitis) 01/2023 - 04/2022
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023 - 01/2021
2	Carcinogenesis 01/2023 - 05/2011
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2022 - 03/2021
2	Thrombocytopenia (Thrombopenia) 10/2020 - 07/2015
2	Lung Neoplasms (Lung Cancer) 01/2019 - 11/2004
2	Melanoma (Melanoma, Malignant) 11/2017 - 01/2016
2	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2017 - 01/2017
2	Chromosomal Instability (Chromosome Stability) 08/2017 - 06/2012

Drug/Important Bio-Agent (IBA)

34	Biomarkers (Surrogate Marker)IBA 03/2024 - 12/2010
34	Trastuzumab (Herceptin)FDA Link 01/2024 - 11/2004
33	Hormones (Hormone)IBA 03/2024 - 07/2005
32	Estrogen ReceptorsIBA 11/2023 - 01/2005
24	human ERBB2 proteinIBA 03/2024 - 06/2012
19	palbociclibIBA 01/2024 - 07/2015
18	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2016
15	ErbB Receptors (EGF Receptor)IBA 01/2023 - 03/2015
14	Phenobarbital (Luminal)FDA Link 01/2024 - 04/2007
13	Fulvestrant (Faslodex)FDA Link 01/2022 - 07/2015
10	AnthracyclinesIBA 01/2023 - 07/2011
9	RNA (Ribonucleic Acid)IBA 12/2023 - 12/2011
9	Lapatinib (GW572016)FDA Link 11/2023 - 04/2015
9	Tamoxifen FDA LinkGeneric 01/2023 - 03/2007
8	pembrolizumabIBA 12/2023 - 01/2018
8	taxaneIBA 01/2023 - 10/2014
8	130-nm albumin-bound paclitaxelIBA 01/2022 - 11/2018
7	Letrozole (Femara)FDA LinkGeneric 03/2024 - 12/2011
7	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 07/2015
7	atezolizumabIBA 10/2022 - 11/2018
7	B7-H1 AntigenIBA 01/2022 - 11/2018
6	pertuzumabIBA 01/2024 - 01/2017
6	Messenger RNA (mRNA)IBA 01/2023 - 02/2013
6	Epidermal Growth Factor (EGF)IBA 01/2023 - 04/2011
6	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2017 - 11/2012
5	neratinibIBA 01/2024 - 10/2018
5	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 11/2004
5	Phosphotransferases (Kinase)IBA 01/2020 - 01/2018
4	LigandsIBA 05/2024 - 01/2018
4	Formaldehyde (Formol)FDA Link 12/2023 - 10/2014
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 07/2015
4	ParaffinIBA 12/2023 - 10/2014
4	Capecitabine (Xeloda)FDA Link 01/2023 - 01/2020
4	exemestane (Aromasin)FDA Link 01/2023 - 07/2015
4	tucatinibIBA 01/2023 - 01/2020
4	Ado-Trastuzumab EmtansineIBA 01/2023 - 01/2020
4	Docetaxel (Taxotere)FDA Link 01/2023 - 03/2013
3	Aromatase InhibitorsIBA 03/2024 - 12/2010
3	Estrogens (Estrogen)FDA Link 01/2023 - 08/2008
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2023 - 07/2015
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 02/2015
3	Cyclin-Dependent Kinase 4IBA 08/2022 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2015
3	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 03/2007
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2019 - 03/2016
3	Everolimus FDA Link 01/2019 - 01/2013
3	Monoclonal AntibodiesIBA 01/2018 - 04/2011
3	InterferonsIBA 01/2017 - 08/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2013 - 07/2011
2	Anastrozole (Arimidex)FDA LinkGeneric 03/2024 - 01/2016
2	ribociclibIBA 03/2024 - 01/2023
2	Tyrosine Kinase InhibitorsIBA 01/2024 - 01/2019
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2023 - 11/2018
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2023 - 01/2017
2	Immunoconjugates (Immunoconjugate)IBA 10/2023 - 01/2021
2	trastuzumab deruxtecanIBA 10/2023 - 01/2023
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2023 - 04/2022
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2023 - 09/2017
2	Hematoxylin (Haematoxylon)IBA 01/2023 - 09/2017
2	Alanine Transaminase (SGPT)IBA 04/2022 - 10/2020
2	Gemcitabine FDA Link 01/2022 - 12/2020
2	CateninsIBA 01/2021 - 08/2014
2	Circulating Tumor DNAIBA 01/2021 - 01/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 12/2010
2	AntibodiesIBA 01/2020 - 01/2017
2	Adenosine (Adenocard)FDA LinkGeneric 03/2017 - 01/2016
2	Chimeric Antigen ReceptorsIBA 03/2017 - 01/2017
2	AutoantigensIBA 03/2017 - 01/2017
2	Epirubicin (Ellence)FDA LinkGeneric 02/2017 - 07/2015

Therapy/Procedure

92	Therapeutics 04/2024 - 03/2007
47	Drug Therapy (Chemotherapy) 01/2024 - 01/2011
32	Immunotherapy 04/2024 - 01/2013
21	Neoadjuvant Therapy 01/2024 - 11/2011
8	Adjuvant Chemotherapy 01/2024 - 07/2005
5	Radiotherapy 01/2024 - 01/2016
3	Drug Tapering 10/2022 - 07/2005